Telix Pharmaceuticals (ASX:TLX) Reports H1 2025 Financial Results
Telix Pharmaceuticals (ASX:TLX) reports a 63% revenue increase in H1 2025, emphasizing strong growth and strategic investments for future expansion.
Telix Pharmaceuticals (ASX:TLX) reports a 63% revenue increase in H1 2025, emphasizing strong growth and strategic investments for future expansion.
Lark Distilling Co. Ltd (ASX:LRK) reports a 2.6% revenue increase in FY25, emphasizing strategic partnerships and notable growth initiatives despite a rise in losses.
MAAS Group Holdings Limited (ASX:MGH) releases its FY25 preliminary final report, showing a 15% revenue increase and announcing interim and final dividends.
Objective Corporation Limited (ASX:OCL) reports a 13% increase in FY2025 net profit and declares final unfranked dividends.
Aspen Group (ASX:APZ) announces FY25 results, exceeding guidance with significant increases in underlying EPS and NAV per security.
Universal Store Holdings (ASX:UNI) reports a 15.5% sales increase and 15.9% rise in EBIT for FY25, with a higher dividend payout.
Telix Pharmaceuticals (ASX:TLX) reports a 63% revenue increase in H1 2025, maintaining strong financial and operational growth.
Super Retail Group (ASX:SUL) reports FY25 results with sales up 4.5% and declares dividends totaling 96 cents per share.
Magellan Financial Group Ltd (ASX:MFG) announces FY25 financial results, including net profit, dividends, and strategic growth initiatives.
Schaffer Corporation Limited (ASX:SFC) reports a statutory NPAT of $24.3 million for FY25 and declares a final dividend of $0.45 per share.